Navigation Links
Newly Formed American Society for Nanomedicine (ASNM) to Hold First Conference (www.amsocnanomed.org)
Date:9/4/2009

ASHBURN, Va., Sept. 4 /PRNewswire-USNewswire/ -- Nanomedicine - the science and technology of diagnosing, treating and preventing disease to improve human health using nanotechnology - has the potential to revolutionize healthcare. Current and future products range from miniaturized "smart pills" that precision-target certain cancers to nanosensors that are capable of navigating through the body for early detection of disorders. These approaches have the ability to reduce toxicity for the patient, thereby improving efficacy and patient compliance. The newly formed American Society for Nanomedicine (ASNM) is holding its inaugural conference on October 22-25, 2009 in the Washington D.C. area, where some of the biggest stakeholders in this emerging technology operate and practice.

This major interdisciplinary international conference is designed for physicians, scientists, policy-makers, engineers, lawyers and educators from government, academia and industry. The conference venue is the Bolger Center in Potomac, Maryland, USA (http://www.dolce-bolger-center-hotel.com/).

This four-day conference will highlight numerous cutting-edge presentations broken up into various sessions focusing on innovations in nanomedicine and applications of nanotechnology to the pharmaceutical, device and biotechnology industries. It will feature more than forty speakers, who are among the top researchers and leaders in various facets of nanomedicine throughout the world. The areas of emphasis are clinical applications of nanotechnology enabling successful vaccine development, effective cancer therapy and novel drug delivery approaches. In addition, issues such as ethics, safety and toxicity, patent law, intellectual property and commercialization will be addressed. Poster sessions, an award ceremony and numerous networking opportunities are included.

About American Society for Nanomedicine

American Society for Nanomedicine (ASNM) is a professional non-profit, medical society headquartered in Ashburn, Virginia, USA. It promotes worldwide seminal research activities in nanomedicine and explores the applications of nanotechnology in the pharmaceutical, device and biotechnology industries. Members also discuss issues such as ethics, toxicity, patents and commercialization. They are drawn from diverse and overlapping fields such as biotechnology, engineering, medicine, policy and law. Members enjoy numerous benefits, including reduced rates to attend ASNM conferences and discounted rates to ASNM-affiliated journals.

Contacts

Dr. Esther Chang, Acting President, American Society for Nanomedicine; Professor of Oncology, Georgetown University Medical Center, Washington, D.C., USA; Phone: +202 687 8418 esther.chang9@gmail.com

Dr. Raj Bawa, Acting Secretary, American Society for Nanomedicine; President, Bawa Biotechnology Consulting, 21005 Starflower Way, Ashburn, Virginia, USA; Phone: +703 582 1745 bawa@bawabiotech.com

Conference Information/Registration: www.amsocnanomed.org


'/>"/>
SOURCE American Society for Nanomedicine
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Familiar and newly learned words are processed by the same neural networks in the brain
2. Newly discovered mechanism in cell division has implications for chromosomes role in cancer
3. MRI may be unnecessary prior to treatment in most newly diagnosed breast cancer patients
4. Newly Published Research Indicates 97% of Apraxic Children Improving with Novel Nutritional Combination
5. Exploring Newly Found Freedom with the GaitAid for Parkinson's Disease
6. Nephrologists Indicate High Interest in AMAG Pharmaceuticals Newly Approved Feraheme According to Latest BioTrends Report
7. Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)
8. ONRAD Announces Newly Bundled Services for a Single Package Price
9. Dr. John L. LeRoy First Atlanta Plastic Surgeon to Perform Newly Approved Dysport Wrinkle Remover Injections for Facial Rejuvenation
10. Newly Patented Sterilization/Disinfection Method Reduces Risk of Microorganism Growth on Hard Surfaces
11. Accumetrics VerifyNow(R) P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly-Approved Prasugrel (Effient(R))
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , ... December 07, 2016 , ... "Hacking into my ... had described him as 'a genius.'" Thus begins "Margaret in Berlin," Book Twelve in ... published by Wyston Books, Inc. These novels narrate the lives of a ...
(Date:12/6/2016)... ... December 06, 2016 , ... Men with gum ... risk of serious health problems, such as cardiovascular illness, according to research cited ... Beverly Hills Periodontics & Dental Implant Center notes that the correlation between periodontal ...
(Date:12/6/2016)... ... ... An inventor, from Talladega, Ala., thought there needed to be a more ... , The SLING-VEST provides an effective way to support and align the arm or ... result, it helps to reduce discomfort and shifting. The invention features an effective design ...
(Date:12/6/2016)... ... ... Mount Sinai Health System today announced the creation of the Medical Modeling ... order 3D models for their cases. Virtual reality, simulation, and 3D printing services ... resource will be the first of its kind catering to the unique patient-specific modeling ...
(Date:12/6/2016)... Scottsdale, Arizona (PRWEB) , ... December 06, 2016 , ... ... less than fIve days after launch. Almost 200 backers pledged more than $25,000 ... life-changing technology. , Dr. Amy Serin, an Arizona Neuropsychologist and inventor, ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016 Two new ... personnel in a simulated mass casualty event Tuesday at ... . The technology debuted before an audience including ... and representatives from Homeland Security, Federal Law Enforcement Agencies, ... Project, known as HiRO (Health Integrated Rescue Operations), was ...
(Date:12/6/2016)... JOLLA, Calif. , Dec. 6, 2016 /PRNewswire/ ... a biopharmaceutical company leading the discovery and development ... new drug development candidates at its R&D day, ... The first candidate, RGLS5040, is an anti-miR targeting ... The second candidate, RGLS4326, is an anti-miR targeting ...
(Date:12/6/2016)... , Dec. 6, 2016  BioAtla, ... the development of Conditionally Active Biologic (CAB) ... Beijing Sinobioway Group Company, Limited (Sinobioway) selected ... development.  The specific program candidates and the ... 2015, BioAtla and Sinobioway entered into a ...
Breaking Medicine Technology: